Cantor Fitzgerald raised its price objective and issued an overweight rating on Progyny stock.
2 reports, 1 independent
Updated Jul 1
Gone quiet
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Cantor Fitzgerald raised its price objective and issued an overweight rating on Progyny stock.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Progyny, Inc.
fertility benefits management company
Nothing else this week.
-
Cantor Fitzgerald
American financial services company
Related events
- Cantor Fitzgerald reiterated an Overweight rating on Amazon stock.
- Cantor Fitzgerald reiterated an overweight rating on CleanSpark shares.
- Cantor Fitzgerald raised its price target and rating for Supernus Pharmaceuticals, Inc. on September 2, 2026, and the company filed a disclosure with the SEC.
- Cantor Fitzgerald raised its price target and rating, while Bank of America adjusted its rating and price target, with MarketBeat aggregating the stock rating data.
- Cantor Fitzgerald raised its price target on PagerDuty following a review of the company's financials on August 28, 2026.
Coverage
Newest first; wire copies grouped- StockStoryProgyny (PGNY) Stock Trades Up, Here Is Why Shares of fertility benefits company Progyny (NASDAQ:PGNY) jumped 3.1% in the morning session after JPMorgan raised its price target on the company's stock